Clinical Trials Browser

Phase 2 × perifosine × Breast × Clear all

NCT00054145 2015-07-23

Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male